Carvone Metabolism Mechanisms
J. Agric. Food Chem., Vol. 50, No. 6, 2002 1687
Purification of the Acidic Metabolites by High-Pressure Liquid
Chromatography (HPLC). The ethylated mixture of the acidic
metabolites was concentrated to about 50 µL and diluted with pentane
to a total volume of 100 µL. HPLC separation was performed in a
single run on a polar diol phase column (250 mm × 4.6 mm i. d.;
Lichrospher 100 Diol, 5 µm, Merck, Darmstadt, Germany) using a
pentane-diethyl ether gradient at a flow of 1 mL/min. The gradient
started with pentane/diethyl ether 92:8, v/v, and was raised within 40
min to a final concentration of pentane/diethyl ether 12:88, v/v.
Fractions were collected at 1-min. intervals, concentrated, and checked
by HRGC-MS for the presence of the ethyl esters of M1 (M1-ET) or
M2 (M2-ET). Both acids were localized in the fraction eluting between
12 and 13 min.
High-Resolution Gas Chromatography (HRGC)-Mass Spec-
trometry (MS). High-resolution gas chromatography was performed
using a nonpolar capillary column (30 m × 0.25 mm i. d.; DB-5,
J + W Scientific, Folsom, CA) in a model 5890 gas chromatograph
(Hewlett Packard, Heilbronn, Germany). Sample injection was per-
formed using the cold on-column technique. The volume injected ranged
from 0.2 to 0.5 µL. The temperature during HRGC was held at 35 °C
for 1 min and raised to 230 °C with a rate of 6 °C/min. Mass spectra
were recorded on a Finnigan MAT 95S (Finnigan, Bremen, Germany)
mass spectrometer in the electron ionization (EI) mode at 70 eV, in
the chemical ionization (CI) mode at 115 eV with isobutane as reagent
gas, and in high-resolution (HR) mode using perfluorokerosene as
internal standard.
Synthesis of 9,9-Dideutero-Carvone and 9-13C-Carvone. 5-(1,2-
dihydroxy-1-methylethyl)-2-methyl-2-cyclohexen-1-one. The synthesis
was performed as described earlier (1). Briefly, carvone was epoxy-
genated, and the epoxide was cleaved by H2SO4 in aqueous THF.
5-Acetyl-2-methyl-2-cyclohexen-1-one. To a stirred solution of 5-(1,2-
dihydroxy-1-methylethyl)-2-methyl-2-cyclohexen-1-one (6.5 mmol, 1.2
g) in methanol (10 mL) and water (10 mL), a solution of sodium
metaperiodate (6.5 mmol, 1.4 g) in water (20 mL) was added dropwise
within 20 min. The mixture was stirred for further 40 minutes during
which a white precipitate appeared. The methanol was evaporated under
vacuum using a rotary evaporator, and the target compound was
extracted from the aqueous phase with diethyl ether (2 × 200 mL).
The extract was dried over Na2SO4 and evaporated to dryness. Yield
of 5-acetyl-2-methyl-2-cyclohexen-1-one was 82% (810 mg, 5.33
mmol); elemental composition (HRMS): C9H12O2, found (152.0845),
calculated (152.0834). MS (EI): m/z (relative intensity) 109 (100), 43
RESULTS AND DISCUSSION
Possible Mechanisms of Oxidative In Vivo Metabolism.
It is generally accepted that metabolism of xenobiotics starts
with either hydroxylation or epoxidation and, therefore, the
following mechanisms seem possible to explain the formation
of dihydrocarvonic acid (M1) and carvonic acid (M2) during
oxidative in vivo metabolism of carvone. In pathway 1 (Figure
1) carvone epoxide would be the first intermediate, which after
isomerization to the aldehyde and subsequent further oxidation
would lead to M1. Consequently, M2 would be a dehydroge-
nation product of M1. In pathway 1 the carboxy carbon atom
of both the acids is derived from the methylene carbon atom of
carvone. Pathway 2 (Figure 1) starts with hydroxylation at the
methyl group of the isopropenyl side chain of carvone yielding
an alcohol (3) which after further oxidation leads to M2.
Hydrogenation of the latter will result in formation of M1. The
carboxy carbon of the acids is now derived from the methyl
carbon of the isopropenyl side chain of carvone. Finally, in
pathway 3, a stabilized radical could be formed by hydrogen
abstraction prior to oxidation leading to equivalency of the
methyl and the methylene position yielding the acids M1 and
M2 with a 50% scrambling of methyl- and methylene-derived
carboxy groups.
1
(24), 81 (18), 79 (16), 95 (14), 108 (12), 53 (12), 82 (11). H NMR
(CDCl3): CH3-Cd (1.79, s, 3H), CH3-CdO (2.21, s, 3H), -CH2-
CH-CH2- (2.47-2.73, m, 4H), CH-CdO (3.07-3.17, m, 1H), CHd
C (6.71, m, 1H). 13C NMR (CDC3): CH3-Cd (15.6, DEPT +), CH2-
CHd (27.4, DEPT -), CH3-CdO (27.7, DEPT +), CH2-CdO (39.3,
DEPT -), CH-CdO (47.0, DEPT +), CH3-Cd (135.7, DEPT 0),
CH2-CHd (142.5, DEPT +), CH2-CdO (197.4, DEPT 0), CH3-
CdO (207.7, DEPT 0).
5-(2,2-dideutero-1-methylethenyl)-2-methyl-2-cyclohexen-1-one (9,
9-dideutero-carVone) and 5-(1-methyl-2-(13C)-ethenyl)-2-methyl-2-cy-
clohexen-1-one. A suspension of either 13C-methyl- or D3-methyl-
triphenyl-phosphonium bromide (2) (2.5 mmol, 1.0 g) in dry diethyl
ether (100 mL, dried over NaH) was stirred under a nitrogen
atmosphere, and a solution of butyllithium in hexane (1 mL, 2.5 mmol/
mL) was added dropwise at room temperature. The deep orange mixture
was stirred for an additional 10 min, and a solution of 5-acetyl-2-methyl-
2-cyclohexen-1-one (2.5 mmol, 380 mg) in dry diethyl ether (10 mL)
was then added dropwise. Stirring was continued for further 60 min,
after which the reaction mixture was washed with a solution of
KH2PO4 (3 mmol, 408 mg) in water (50 mL). The diethyl ether phase
was dried over Na2SO4 and evaporated to dryness by means of a rotary
evaporator at a water bath temperature of 37 °C. By HRGC the purity
of the crude product was in the range of 50-70% with a major impurity
of unreacted 5-acetyl-2-methyl-2-cyclohexen-1-one of approximately
20-40%. The crude reaction mixture was purified by column chro-
matography on a diol phase (Bakerbond Diol, 40 µm, pentane/diethyl
ether gradient). Yield of purified 5-(2,2-dideutero-1-methylethenyl)-
2-methyl-2-cyclohexen-1-one (9,9-dideutero-carvone) was 16% (62.5
mg, 0.41 mmol); purity 95% determined by HRGC; isotopic purity
determined by MS(CI) 94% D2, 5% 6 D1, 1% D0; elemental composition
(HRMS): C10H12D2O, found (152.1159), calculated (152.1165). MS
(EI), m/z (relative intensity) 82 (100), 110 (50), 95 (40), 109 (36), 54
(35), 39 (32), 107 (28), 41 (20), 152 (18). Yield of purified 5-(1-methyl-
2(13C)-ethenyl)-2-methyl-2-cyclohexen-1-one (9-13C-carvone) was 11%
(42.3 mg, 0.28 mmol); purity 97% determined by HRGC; isotopic purity
determined by MS(CI) 99%; elemental composition (HRMS): C913CH14O,
found (151.1059), calculated (151.1075). MS (EI), m/z (relative
intensity) 82(100), 109 (53), 94 (51), 54 (49), 108 (30), 107 (28), 39
(18), 41 (15), 151 (14).
For uroterpenolone (M3) also three possible pathways of
formation can be postulated (Figure 1). The primary alcohol
function of M3 might stem from either the methylene group
(pathway 1) or the methyl group (pathway 2) of the isopropenyl
side chain of carvone. Additionally, there might also be a
pathway operative in which scrambling occurs (pathway 3). In
pathway 1 the hypothetical intermediate carvone epoxide is
hydrated, whereas in pathways 2 and 3 hydration occurs at the
double bond of 10-hydroxy-carvone, a compound that has been
identified as a carvone metabolite in rabbits (3).
Synthesis of 9,9-Dideutero-carvone or 9-13C-Carvone. On
the basis of the postulated oxidation mechanisms (Figure 1)
only the positions 9 and 10 of carvone are suitable for labeling.
The following straightforward approach was developed to
synthesize carvone labeled at the methylene position at carbon
9. The synthesis started from unlabeled carvone which was
epoxygenated to yield 8,9-epoxy-carvone. The epoxide was
hydrolyzed with diluted sulfuric acid in water/THF producing
uroterpenolone which was cleaved with sodium metaperiodate
yielding 5-acetyl-2-methyl-2-cyclohexen-1-one. From reaction
of the latter with dideutero-methylene-triphenylphosphorane or
with 13C-methylene-triphenylphosphorane in a Wittig Reaction
either 9,9-dideutero-carvone or 9-13C-carvone was obtained
(Figure 2).
Deuterium Distribution in M1 and M2 from 9,9-Dideu-
tero-carvone. The deuterium-labeled carvone was metabolized
in a MICA experiment, and the metabolites were obtained as
NMR Spectroscopy. NMR spectra were recorded on a Bruker AM
360 (Bruker, Karlsruhe, Germany) in CDCl3 with TMS as internal
standard (δ ) 0 ppm).